Back to Journals » Journal of Hepatocellular Carcinoma » Hepatocellular Carcinoma among US patients
SJR OA
CiteScore
Impact Factor
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (1079)
- Volume 13, 2026 (153)
- Volume 12, 2025 (220)
- Volume 11, 2024 (181)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- Immune Checkpoint Inhibitors (PD-1/PD-L1) in Hepatocellular Carcinoma Treatment (4)
- Addressing Global Differences in HCC Risk Factors and Management Strategies (2)
- Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (7)
- Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (6)
- The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
- Combination of Immune Checkpoint Inhibitors and Locoregional Therapy of Hepatocellular Carcinoma: Hype or Hope (1)